Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Takeda Pharmaceutical Co Ltd Wave 1 Pipeline Market Opportunity Call Transcript

Dec 08, 2020 / 10:00PM GMT
Release Date Price: $18.97 (+1.07%)
Christopher David O;Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance

' -

[Interpreted] Good morning. Thank you very much for joining Takeda Pharmaceuticals Wave 1 Pipeline Market Opportunity Call. I am O'Reilly, Global IR Head. I'd like to serve as the moderator today.

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 1 of the presentation today.

Now let me introduce you today's agenda and the speakers. First, Christophe Weber, President and CEO, makes you introduction; followed by Andy Plump, R&D President, introduce you R&D strategies; and next, U.S. Business Unit President and Global Portfolio Commercialization President, Ramona Sequeira, will discuss

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot